Innate Immune Signaling Pathways in Animals: Beyond Reductionism

REFERENCES

• Litman G., Cannon J., Dishaw L. Reconstructing immune phylogeny: New perspectives. Nat Rev Immunol 2005; 5: 866–879
   PubMed Web of Science ®Google Scholar
• Akira S., Takeda K., Kaisho T. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675–680
   PubMed Web of Science ®Google Scholar
• Pearlman E., Johnson A., Adhikary G., Sun Y., Chinnery H. R., Fox T., Kester M., McMenamin P. G. Toll-like receptors at the ocular surface. Ocul Surf 2008; 6: 108–116
   PubMed Web of Science ®Google Scholar
• Takeuchi O., Kawai T., Sanjo H., Copeland N. G., Gilbert D. J., Jenkins N. A., Takeda K., Akira S. TLR6: A novel member of an expanding toll-like receptor family. Gene 1999; 231: 59–65
   PubMed Web of Science ®Google Scholar
• Kopp E. B., Medzhitov R. The Toll-receptor family and control of innate immunity. Curr Opin Immunol 1999; 11: 13–18
   PubMed Web of Science ®Google Scholar
• Medzhitov R., Preston-Hurlburt P., Kopp E., Stadlen A., Chen C., Ghosh S., Janeway C. A. Jr., MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 1998; 2: 253–258
   PubMed Web of Science ®Google Scholar
• Burns K., Clatworthy J., Martin L., Martinon F., Plumpton C., Maschera B., Lewis A., Ray K., Tschopp J., Volpe F. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat Cell Biol 2000; 2: 346–351
   PubMed Web of Science ®Google Scholar
• Cao Z., Xiong J., Takeuchi M., Kurama T., Goeddel D. V. TRAF6 is a signal transducer for Interleukin-1. Nature 1996; 383: 443–446
   PubMed Web of Science ®Google Scholar
• Medzhitov R., Laneway C. Jr., Advance in immunology. New Engl J Med 2000; 343: 338–344
   PubMed Web of Science ®Google Scholar
• An G. C., Faeder J. R. Detailed qualitative dynamic knowledge representation using a BioNetGen model of TLR-4 signaling and preconditioning. Math Biosci 2008; 217: 53–63
   Google Scholar
• Kagan J. C., Su T., Horng T., Chow A., Akira S., Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β. Nature Immunol 2008; 9: 361–368
   PubMed Web of Science ®Google Scholar
• Wenekamp J., Henneke P. Induction and termination of inflammatory signaling in group B streptococcal sepsis. Immunol Rev 2008; 225: 114–127
   Google Scholar
• Tenoever B. R., Maniatis T. Parallel pathways of virus recognition. Immunity 2006; 24: 633–642
   Google Scholar
• Edwards A. D., Manickasingham S. P., Spörri R., Diebold S. S., Schulz O., Sher A., Kaisho T., Akira S., Reis e Sousa C. Microbial recognition via Toll-like receptor-dependent and independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering. J Immunol 2002; 169: 3652–3660
   Google Scholar
• Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., Modlin R. L., Akira S. Cutting edge: Role of Toll-like receptor l in mediating immune response to microbial lipoproteins. J Immunol 2002; 169: 10
   PubMed Web of Science ®Google Scholar
• Medzhitov R., Janeway C., Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev 2000; l73: 89–97
   Google Scholar
• Bowie A., O'Neill L. A. The interleukin-1 receptor Toll-like receptor superfamily: Signal generators for pro-inflammatory interleukins and microbial products. J Leukoc Biol 2000; 67: 508–514
   PubMed Web of Science ®Google Scholar
• Hatada E. N., Krappmann D., Scheidereit C. NF-κ B and the innate immune response. Curr Opin Immunol 2000; 12: 52–58
   PubMed Web of Science ®Google Scholar
• Lai Y., Gallo R. L. Toll-like receptors in skin infections and inflammatory diseases. Infect Disord Drug Targets 2008; 8: 144–155
   PubMedGoogle Scholar
• Hritz I., Mandrekar P., Velayudham A., Catalano D., Dolganiuc A., Kodys K., Kurt-Jones E., Szabo G. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology 2008; 48: 1224–1231
   PubMed Web of Science ®Google Scholar
• Cattaneo E., Conti L., De-Frajia C. Signaling through the JAK/STAT pathway in the developing brain. Trends Neurosci 1999; 22: 365–369
   PubMed Web of Science ®Google Scholar
• Benekli M., Baer M. R., Baumann H., Wetzler M. Signal transducer and activator of transcription proteins in leukemias. Blood 2003; l0l: 2940–2954
   Google Scholar
• Sternberg D. W., Gilliland D. G. The role of signal transducer and activator of transcription factors in leukemogenesis. J Clin Oncol 2004; 22: 361–337
   Google Scholar
• Leonard W. J., O'Shea J. J. Jaks and STATs: Biological implications. Annu Rev Immnol 1998; 16: 293–322
   PubMed Web of Science ®Google Scholar
• Smirnova O. V., Ostroukhova T. Y., Bogorad R. L. JAK-STAT pathway in carcinogenesis: Is it relevant to cholangiocarcinoma progression?. World J Gastroenterol 2007; 13: 6478–6491
   Google Scholar
• Bolli R., Dawn B., Xuan Y. T. Role of the JAK—STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends Cardiovasc Med 2003; 13: 72–79
   PubMed Web of Science ®Google Scholar
• Booz G. W., Day J. N., Baker K. M. Interplay between the cardiac rennin angiotensin system and JAK/STAT signaling: Role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. J Mol Cell Cardiol 2002; 34: 1443–1453
   PubMed Web of Science ®Google Scholar
• Sagawa M., Nakazato T., Uchida H., Ikeda Y., Kizaki M. Cantharidin induces apoptosis of human multiple myeloma cells via inhibition of the JAK/STAT pathway. Cancer Sci 2008; 99: 1820–1826
   PubMed Web of Science ®Google Scholar
• Kim B. H., Yin C. H., Guo Q., Bach E. A., Lee H., Sandoval C., Jayabose S., Ulaczyk-Lesanko A., Hall D. G., Baeg G. H. A small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cells. Mol Cancer Ther 2008; 7: 2672–2680
   PubMedGoogle Scholar
• Levine R. L., Gilliland D. G. Myeloproliferative disorders. Blood 2008; 112: 2190–2198
   PubMed Web of Science ®Google Scholar
• Maher S. G., Sheikh F., Scarzello A. J., Romero-Weaver A. L., Baker D. P., Donnelly R. P., Gamero A. M. IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity. Cancer Biol Ther 2008; 7: 1109–1115
   PubMed Web of Science ®Google Scholar
• Baltayiannis G., Baltayiannis N., Tsianos E. V. Suppressors of cytokine signaling as tumor repressors. Silencing of SOCS3 facilitates tumor formation and growth in lung and liver. J BUON 2008; 13: 263–265
   PubMed Web of Science ®Google Scholar
• Cardoso B. A., Gírio A., Henriques C., Martins L. R., Santos C., Silva A., Barata J. T. Aberrant signaling in T-cell acute lymphoblastic leukemia: Biological and therapeutic implications. Braz J Med Biol Res 2008; 41: 344–350
   Google Scholar
• Yamamoto K., Kobayashi H., Arai A., Miura O., Hirosawa S., Miyasaka N. cDNA cloning, expression and chromosome mapping of the human STAT4 gene: Both STAT4 and STAT1 genes are mapped to 2q32.2-q32.3. Cytogenet Cell Genet 1997; 77: 207–210
   Google Scholar
• Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). J Immunol 1995; 155: 1151–1164
   PubMed Web of Science ®Google Scholar
• Frank D. A., Mabajan S., Ritz J. B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription STAT1 and STAT3 constitutively phosphorylated on serine residues. J Clin Invest 1997; 100: 3140–3148
   PubMed Web of Science ®Google Scholar
• Li W. X. Canonical and non-canonical JAK-STAT signaling. Trends Cell Biol 2008; 18: 545–551
   PubMed Web of Science ®Google Scholar
• Pfeifer A. C., Timmer J., Klingmüller U. Systems biology of JAK/STAT signaling. Essays Biochem 2008; 45: 109–120
   Google Scholar
• Dostert C., Jouanguy E., Irving P., Troxler L., Galiana-Arnoux D., Hetru C., Hoffmann J. A., Imler J. L. The Jak-STAT signaling pathway is required but not sufficient for the antiviral response of drosophila. Nat Immunol 2005; 6: 946–953
   PubMed Web of Science ®Google Scholar
• Murray P. J. The JAK-STAT signaling pathway: Input and output integration. J Immunol 2007; 178: 2623–2629
   PubMed Web of Science ®Google Scholar
• Mao X., Ren Z., Parker G. N., Sondermann H., Pastorello M. A., Wang W., McMurray J. S., Demeler B., Darnell J. E., Jr., Chen X. Structural bases of unphosphorylated STAT1 association and receptor binding. Mol Cell 2005; 17: 761–771
   PubMed Web of Science ®Google Scholar
• Ndubuisi M. I., Guo G. G., Fried V. A., Etlinger J. D., Sehgal P. B. Cellular physiology of STAT3: Where's the cytoplasmic monomer?. J Biol Chem 1999; 274: 25499–25509
   PubMedGoogle Scholar
• Bonifacino J. S. Quality control of receptor-kinase signaling complexes. Dev Cell 2002; 2: 1–2
   PubMedGoogle Scholar
• Hofmann S. R., Lam A. Q., Frank S., Zhou Y. J., Ramos H. L., Kanno Y., Agnello D., Youle R. J., O'Shea J. J. JAK3-independent trafficking of the common chain receptor subunit: chaperone function of JAKs revisited. Mol Cell Biol 2004; 24: 5039–5049
   PubMed Web of Science ®Google Scholar
• Pelletier S., Gingras S., Funakoshi-Tago M., Howell S., Ihle J. N. Two domains of the erythropoietin receptor are sufficient for JKA2 binding/activation and function. Mol Cell Biol 2006; 26: 8527–8538
   PubMed Web of Science ®Google Scholar
• Liang S., Wei H., Sun R., Tian Z. IFN-a regulates NK cell cytotoxicity through STAT1 pathway. Cytokine 2003; 2: 190–199
   Google Scholar
• Tassi I., Cella M., Presti R., Colucci A., Gilfillan S., Littman D. R., Colonna M. NK cell activating receptors require PKC {theta} for sustained signaling, transcriptional activation and IFN-{gamma} secretion. Blood 2008; 112: 4109–4116
   PubMed Web of Science ®Google Scholar
• Kijima M., Yamaguchi T., Ishifune C., Maekawa Y., Koyanagi A., Yagita H., Chiba S., Kishihara K., Shimada M., Yasutomo K. Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. Proc Natl Acad Sci U S A 2008; 105: 7010–7015
   PubMed Web of Science ®Google Scholar
• Sun P. D. Structure and function of natural-killer-cell receptors. Immunol Res 2003; 27: 539–548
   PubMed Web of Science ®Google Scholar
• Gewurz B. E., Wang E. W., Tortorella D., Schust D. J., Ploegh H. L. Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner. J Virol 2001; 75: 5197–5204
   Google Scholar
• Snyder M. R., Weyand C. M., Goronzy J. J. The double life of NK receptors: Stimulation or co-stimulation?. Trends Immunol 2004; 25: 25–32
   PubMed Web of Science ®Google Scholar
• Strong R. K., McFarland B. J. NKG2D and related immunoreceptors. Adv Protein Chem 2004; 68: 281–312
   Google Scholar
• Vyas Y. M., Maniar H., Dupont B. Visualization of signaling pathways and cortical cytoskeleton in cytolytic and noncytolytic natural killer cell immune synapses. Immunol Rev 2002; 189: 161–178
   PubMed Web of Science ®Google Scholar
• Veillette A. Specialised adaptors in immune cells. Current Opin Cel1 Bio1 2004; 16: 146–155
   Google Scholar
• Rudd C. E., Wang H. Hematopoietic adaptors in T-cell signaling: Potential applications to transplantation. Am J Transplant 2003; 3: 1204–1210
   PubMedGoogle Scholar
• Kim D. H., Ausubel F. M. Evolutionary perspectives on innate immunity from the study of Caenorhabditis elegans. Curr Opin Immunol 2005; 17: 4–10
   PubMed Web of Science ®Google Scholar
• Lanier L. L. Natural killer cell receptor signaling. Curr Opin Immunol 2003; 15: 308–314
   PubMed Web of Science ®Google Scholar
• Rivera G. M., Briceño C. A., Takeshima F., Snapper S. B., Mayer B. J. Inducible clustering of membrane-targeted SH3 domains of the adaptor protein nck triggers localized actin polymerization. Current Biol 2004; 14: 11–22
   PubMed Web of Science ®Google Scholar
• Guo H., Samarakoon A., Vanhaesebroeck B., Malarkannan S. The p110 delta of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation. J Exp Med 2008; 205: 2419–2435
   Google Scholar
• Bouchon A., Cella M., Grierson H. L., Cohen J. I., Colonna M. Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. J Immunol 2001; 167: 5517–5521
   PubMed Web of Science ®Google Scholar
• Yu M. C., Su L. L., Zou L., Liu Y., Wu N., Kong L., Zhuang Z. H., Sun L., Liu H. P., Hu J. H., Li D., Strominger J. L., Zang J. W., Pei G., Ge B. X. An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cells. Nat Immunol 2008; 9: 898–907
   PubMed Web of Science ®Google Scholar
• Vasta G. R., Lambris J. D. Innate immunity in the Aegean: Ancient pathways for today's survival. Dev Comp Immunol 2002; 26: 217–225
   Google Scholar
• Hanna J., Goldman-Wohl D., Hamani Y., Avraham I., Greenfield C., Natanson-Yaron S., Prus D., Cohen-Daniel L., Arnon T. I., Manaster I., Gazit R., Yutkin V., Benharroch D., Porgador A., Keshet E., Yagel S., Mandelboim O. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006; 12: 1065–1074
   PubMed Web of Science ®Google Scholar
• Sargent I. L., Borzyehowski A. M., Redman C. W. NK cells and human pregnancy—an inflammatory view. Trends Immunol 2006; 27: 399–404
   PubMed Web of Science ®Google Scholar
• Tacke F., Luedde T., Trautwein C. Inflammatory pathways in liver homeostasis and liver injury. Clin Rev Allergy Immunol 2009; 36: 4–12
   PubMed Web of Science ®Google Scholar
• Lettau M., Paulsen M., Kabelitz D., Janssen O. Storage, expression and function of Fas ligand, the key death factor of immune cells. Curr Med Chem 2008; 15: 1684–1696
   PubMed Web of Science ®Google Scholar
• Hu X., Chung A. Y., Wu I., Foldi J., Chen J., Ji J. D., Tateya T., Kang Y. J., Han J., Gessler M., Kageyama R., Ivashkiv L. B. Integrated regulation of Toll-like receptor responses by Notch and interferon-gamma pathways. Immunity 2008; 29: 691–703
   PubMedGoogle Scholar
• Kang T. J., Basu S., Zhang L., Thomas K. E., Vogel S. N., Baillie L., Cross A. S. Bacillus anthracis spores and lethal toxin induce IL-1beta via functionally distinct signaling pathways. Eur J Immunol 2008; 38: 1574–1584
   PubMedGoogle Scholar
• Macedo C., Magalhães D. A., Tonani M., Marques M. C., Junta C. M., Passos G. A. Genes that code for T cell signaling proteins establish transcriptional regulatory networks during thymus ontogeny. Mol Cell Biochem 2008; 318: 63–71
   Google Scholar
• Loza M. J., McCall C. E., Li L., Isaacs W. B., Xu J., Chang B. L. Assembly of inflammation-related genes for pathway-focused genetic analysis. Plos One 2007; 2: e1035
   PubMed Web of Science ®Google Scholar
• Taniguchi C. M., Emanuelli B., Kahn C. R. Critical nodes in signalling pathways: Insights into insulin action. Nat Rev Mol Cell Biol 2006; 7: 85–96
   PubMed Web of Science ®Google Scholar
• Cui X., Lee A. V. Regulatory nodes that integrate and coordinate signaling as potential targets for breast cancer therapy. Clin Cancer Res 2004; 10: 396S–401S
   Google Scholar
• Ouyang X., Negishi H., Takeda R., Fujita Y., Taniguchi T., Honda K. Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation. Biochem Biophys Res Commun 2007; 354: 1045–1051
   PubMed Web of Science ®Google Scholar
• Zhu Q., Egelston C., Vivekanandhan A., Uematsu S., Akira S., Klinman D. M., Belyakov I. M., Berzofsky J. A. Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccines. Proc Natl Acad Sci U S A 2008; 105: 16260–16265
   PubMed Web of Science ®Google Scholar
• Minguet S., Dopfer E. P., Pollmer C., Freudenberg M. A., Galanos C., Reth M., Huber M., Schamel W. W. Enhanced B-cell activation mediated by TLR4 and BCR crosstalk. Eur J Immunol 2008; 38: 2475–2487
   Google Scholar
• Bafica A., Santiago H. C., Goldszmid R., Ropert C., Gazzinelli R. T., Sher A. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J Immunol 2006; 177: 3515–3519
   PubMed Web of Science ®Google Scholar
• Tan A. H., Wong S. C., Lam K. P. Regulation of mouse inducible costimulator (ICOS) expression by Fyn-NFATc2 and ERK signaling in T cells. J Biol Chem 2006; 281: 28666–28678
   PubMed Web of Science ®Google Scholar
• Mikami F., Lim J. H., Ishinaga H., Ha U. H., Gu H., Koga T., Jono H., Kai H., Li J. D. The transforming growth factor-beta-Smad3/4 signaling pathway acts as a positive regulator for TLR2 induction by bacteria via a dual mechanism involving functional cooperation with NF-kappaB and MAPK phosphatase 1-dependent negative cross-talk with p38 MAPK. J Biol Chem 2006; 281: 22397–22408
   Google Scholar
• Dadgostar H., Zarnegar B., Hoffmann A., Qin X. F., Truong U., Rao G., Baltimore D., Cheng G. Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes. Proc Natl Acad Sci U S A 2002; 99: 1497–1502
   PubMed Web of Science ®Google Scholar
• Bendelac A., Fearon D. T. Innate immunity—innate pathways that control acquired immunity. Curr Opin Immunol 1997; 9: 1–3
   PubMed Web of Science ®Google Scholar
• Romani L., Kaufmann S. H. Immunity to fungi. Res Immunol 1998; 149: 277
   PubMedGoogle Scholar
• Kabelitz D., Medzhitov R. Innate immunity—cross-talks with adaptive immunity through pattern recognition receptors and cytokines. Curr Opin Immunol 2007; 19: 1–3
   PubMed Web of Science ®Google Scholar
• Barrionuevo P., Beigier-B M., Ilarregui J. M., Toscano M. A., Bianco G. A., Isturiz M. A., Rabinovich G. A. A novel function for galectin-1 at the crossroad of innate and adaptive immunity: Galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathway. J Immunol 2007; 178: 436–445
   PubMed Web of Science ®Google Scholar
• Rius J., Guma M., Schachtrup C., Akassoglou K., Zinkernagel A. S., Nizet V., Johnson R. S., Haddad G. G., Karin M. NF-kB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature 2008; 453: 807–811
   PubMed Web of Science ®Google Scholar
• Maxwell J. R., Yadav R., Rossi R. J., Ruby C. E., Weinberg A. D., Aguila H. L., Vella A. T. IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway. J Immunol 2006; 177: 234–245
   PubMed Web of Science ®Google Scholar
• Wills-Karp M. Complement activation pathways: A bridge between innate and adaptive immune responses in asthma. Proc Am Thorac Soc 2007; 4: 247–251
   PubMedGoogle Scholar
• Pasare C., Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature 2005; 438: 364–368
   PubMed Web of Science ®Google Scholar
• Ruprecht C. R., Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur J Immunol 2006; 36: 810–816
   PubMed Web of Science ®Google Scholar
• Getz G. S. Bridging the innate and adaptive immune systems. J Lipid Res 2005; 46: 619–622
   PubMed Web of Science ®Google Scholar
• Dawicki W., Marshall J. S. New and emerging roles for mast cells in host defense. Curr Opin Immunol 2007; 19: 31–38
   PubMed Web of Science ®Google Scholar
• Kirwan S. E., Burshtyn D. N. Regulation of natural killer cell activity. Curr Opin Immunol 2007; 19: 46–54
   PubMed Web of Science ®Google Scholar
• Steinman R. M. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271–296
   PubMed Web of Science ®Google Scholar
• Banchereau J., Steinman R. M. Dendritic cells and the control of immunity. Nature 1998; 392: 245–252
   PubMed Web of Science ®Google Scholar
• Katz S. I., Tamaki K., Sachs D. H. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 1979; 282: 324–326
   PubMed Web of Science ®Google Scholar
• Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down regulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 1109–1118
   PubMed Web of Science ®Google Scholar
• Romani N., Gruner S., Brang D., Kämpgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P. O., Steinman R. M., Schuler G. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994; 180: 83–93
   PubMed Web of Science ®Google Scholar
• Szabolcs P., Avigan D., Gezelter S., Ciocon D. H., Moore M. A., Steinman R. M., Young J. W. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-CFU intermediate. Blood 1996; 87: 4520–4530
   PubMed Web of Science ®Google Scholar
• Caux C., Vanbervliet B., Massacrier C., Dezutter-Dambuyant C., de Saint-Vis B., Jacquet C., Yoneda K., Imamura S., Schmitt D., Banchereau J. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF α. J Exp Med 1996; 184: 695–706
   PubMed Web of Science ®Google Scholar
• Caux C., Massacrier C., Vanbervliet B., Dubois B., de Saint-Vis B., Dezutter-Dambuyant C., Jacquet C., Schmitt D., Banchereau J. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor a: II. Functional analysis. Blood 1997; 90: 1458–1470
   PubMed Web of Science ®Google Scholar
• Grouard G., Rissoan M. C., Filgueira L., Durand I., Banchereau J., Liu Y. J. The enigmatic plasmacytoid T cells develop into dendritic cells with IL-3 and CD40-ligand. J Exp Med 1997; 185: 1101–1111
   PubMed Web of Science ®Google Scholar
• Rossi M., Young J. W. Human dendritic cells: Potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J Immunol 2005; 175: 1373–1381
   PubMed Web of Science ®Google Scholar
• Steinman R. M., Hemmi H. Dendritic cells: Translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006; 311: 17–58
   PubMed Web of Science ®Google Scholar
• Akira S. Mammalian Toll-like receptors. Curr Opin Immunol 2003; 15: 5
   PubMed Web of Science ®Google Scholar
• Schnare M., Barton G. M., Holt A. C., Takeda K., Akira S., Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001; 2: 947
   PubMed Web of Science ®Google Scholar
• O'Neill L. A. Toll-like receptor signal transduction and the tailoring of innate immunity: A role for Mal?. Trends Immunol 2002; 23: 296–300
   PubMed Web of Science ®Google Scholar
• Pasare C., Medzhitov R. Toll-like receptors: Linking innate and adaptive immunity. Adv Exp Med Biol 2005; 560: 11–18
   PubMed Web of Science ®Google Scholar
• Kimbrell D. A., Beutler B. The evolution and genetics of innate immunity. Nat Rev Genet 2001; 2: 256–267
   PubMed Web of Science ®Google Scholar
• Schulenburg H., Léopold K. C., Ewbank J. J. Evolution of the innate immune system: the worm perspective. Immunol Rev 2004; 198: 36–58
   PubMed Web of Science ®Google Scholar
• Vorbach C., Capecchi M. R., Penninger J. M. Evolution of the mammary gland from the innate immune system?. BioEssays 2006; 28: 606–616
   PubMed Web of Science ®Google Scholar
• Medzhitov R., Janeway C. A., Jr. An ancient system of host defense. Curr Opin Immunol 1998; 10: 12–15
   PubMed Web of Science ®Google Scholar
• Sackton T. B., Lazzaro B. P., Schlenke T. A., Evans J. D., Hultmark D., Clark A. G. Dynamic evolution of the innate immune system in Drosophila. Nat Genet 2007; 39: 1461–1468
   PubMedGoogle Scholar
• Friedman R., Hughes A. L. Molecular evolution of the NF-kappaB signaling system. Immunogenetics 2002; 53: 964–974
   PubMed Web of Science ®Google Scholar
• Beutler B., Rehli M. Evolution of the TIR, Tolls, and TLRs: Functional inferences from computational biology. Curr Top Microbiol Immunol 2002; 270: 1–21
   PubMed Web of Science ®Google Scholar
• Brennan C. A., Anderson K. V. Drosophila: The genetics of innate immune recognition and response. Annu Rev Immunol 2004; 22: 457–483
   PubMedGoogle Scholar
• Royet J. Infectious non-self recognition in invertebrates: Lessons from Drosophila and other insect models. Mol Immunol 2004; 41: 1063–1075
   PubMedGoogle Scholar
• Aderem A., Ulevitch R. J. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406: 782–787
   PubMed Web of Science ®Google Scholar
• Anderson K. V. Toll signaling pathways in the innate immune response. Curr Opin Immunol 2000; 12: 13–19
   PubMed Web of Science ®Google Scholar
• Christophides G. K., Zdobnov E., Barillas-Mury C., Birney E., Blandin S., Blass C., Brey P. T., Collins F. H., Danielli A., Dimopoulos G., Hetru C., Hoa N. T., Hoffmann J. A., Kanzok S. M., Letunic I., Levashina E. A., Loukeris T. G., Lycett G., Meister S., Michel K., Moita L. F., Müller H. M., Osta M. A., Paskewitz S. M., Reichhart J. M., Rzhetsky A., Troxler L., Vernick K. D., Vlachou D., Volz J., von Mering C., Xu J., Zheng L., Bork P., Kafatos F. C. Immunity-related genes and gene families in Anopheles gambiae. Science 2002; 298: 159–165
   Google Scholar
• Evans J. D., Aronstein K., Chen Y. P., Hetru C., Imler J. L., Jiang H., Kanost M., Thompson G. J., Zou Z., Hultmark D. Immune pathways and defense mechanisms in honey bees Apis mellifera. Insect Mol Biol 2006; 15: 645–656
   PubMed Web of Science ®Google Scholar
• Waterhouse R. M., Kriventseva E. V., Meister S., Xi Z., Alvarez K. S., Bartholomay L. C., Barillas-Mury C., Bian G., Blandin S., Christensen B. M., Dong Y., Jiang H., Kanost M. R., Koutsos A. C., Levashina E. A., Li J., Ligoxygakis P., Maccallum R. M., Mayhew G. F., Mendes A., Michel K., Osta M. A., Paskewitz S., Shin S. W., Vlachou D., Wang L., Wei W., Zheng L., Zou Z., Severson D. W., Raikhel A. S., Kafatos F. C., Dimopoulos G., Zdobnov E. M., Christophides G. K. Evolutionary dynamics of immune-related genes and pathways in disease-vector mosquitoes. Science 2007; 316: 1738–1743
   Google Scholar
• Hughes A. L. Rapid evolution of immunoglobulin superfamily C2 domains expressed in immune system cells. Mol Biol Evol 1997; 14: 1–5
   Google Scholar
• Trowsdale J., Parham P. Mini-review: Defense strategies and immunity-related genes. Eur J Immunol 2004; 34: 7–17
   Google Scholar
• Hoffmann J. A., Reichhart J. M. Drosophila innate immunity: An evolutionary perspective. Nat Immunol 2002; 3: 121–126
   PubMed Web of Science ®Google Scholar
• Ausubel F. M. Are innate immune signaling pathways in plants and animals conserved?. Nat Immunol 2005; 6: 973–979
   PubMed Web of Science ®Google Scholar
• Medzhitov R., Janeway C. Jr., Innate immunity. N Engl J Med 2000; 343: 338–344
   PubMed Web of Science ®Google Scholar
• Gravato-Nobre M. J., Hodgkin J. Caenorhabditis elegans as a model for innate immunity to pathogens. Cell Microbiol 2005; 7: 741–751
   PubMedGoogle Scholar
• Kurz C. L., Ewbank J. J. Caenorhabditis elegans: An emerging genetic model for the study of innate immunity. Nat Rev Genet 2003; 4: 380–390
   PubMed Web of Science ®Google Scholar
• Millet A. C., Ewbank J. J. Immunity in Caenorhabditis elegans. Curr Opin Immunol 2004; 16: 4–9
   PubMed Web of Science ®Google Scholar
• Mushegian A., Medzhitov R. Evolutionary perspective on innate immune recognition. J Cell Biol 2001; 155: 705–710
   PubMed Web of Science ®Google Scholar
• Lucanic M., Cheng H. J. A RAC/CDC-42-independent GIT/PIX/PAK signaling pathway mediates cell migration in C. elegans. PLoS Genet 2008; 4: e1000269
   PubMed Web of Science ®Google Scholar
• Guntermann S., Primrose D. A., Foley E. Dnr1-dependent regulation of the Drosophila immune deficiency signaling pathway. Dev Comp Immunol 2009; 33: 127–134
   Web of Science ®Google Scholar
• Kleino A., Myllymäki H., Kallio J., Vanha-aho L. M., Oksanen K., Ulvila J., Hultmark D., Valanne S., Rämet M. Pirk is a negative regulator of the Drosophila Imd pathway. J Immunol 2008; 180: 5413–5422
   PubMed Web of Science ®Google Scholar
• Shivers R. P., Youngman M. J., Kim D. H. Transcriptional responses to pathogens in Caenorhabditis elegans. Curr Opin Microbiol 2008; 11: 251–256
   PubMed Web of Science ®Google Scholar
• Sanjuan M. A., Green D. R. Eating for good health: Linking autophagy and phagocytosis in host defense. Autophagy 2008; 4: 607–611
   PubMed Web of Science ®Google Scholar
• Sekiya M., Ueda K., Okazaki K., Kikuchi H., Kurata S., Oshima Y. A cyclopentanediol analogue selectively suppresses the conserved innate immunity pathways, Drosophila IMD and TNF-alpha pathways. Biochem Pharmacol 2008; 75: 2165–2174
   PubMed Web of Science ®Google Scholar
• Kanehisa M., Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 2000; 28: 27–30
   PubMed Web of Science ®Google Scholar
• Berenson L. S., Gavrieli M., Farrar J. D., Murphy T. L., Murphy K. M. Distinct characteristics of murine STAT4 activation in response to IL-12 and IFN-alpha. J Immunol 2006; 177: 5195–5203
   PubMed Web of Science ®Google Scholar
• Ramos H. J., Davis A. M., George T. C., Farrar J. D. IFN-alpha is not sufficient to drive Th1 development due to lack of stable T-bet expression. J Immunol 2007; 179: 3792–3803
   PubMed Web of Science ®Google Scholar
• Filip L. C., Mundy N. I. Rapid evolution by positive Darwinian selection in the extracellular domain of the abundant lymphocyte protein CD45 in primates. Mol Biol Evol 2004; 21: 1504–1511
   Google Scholar
• Jiggins F. M., Kim K. W. A screen for immunity genes evolving under positive selection in Drosophila. J Evol Biol 2007; 20: 965–970
   Google Scholar
• Williams E. J., Hurst L. D. The proteins of linked genes evolve at similar rates. Nature 2000; 407: 900–903
   Google Scholar
• Kikuchi H., Itoh J., Fukuda S. Chronic nicotine stimulation modulates the immune response of mucosal T cells to Th1-dominant pattern via nAChR by upregulation of Th1-specific transcriptional factor. Neurosci Lett 2008; 432: 217–221
   Google Scholar
• Wang X., Wang B. R., Zhang X. J., Xu Z., Ding Y. Q., Ju G. Evidences for vagus nerve in maintenance of immune balance and transmission of immune information from gut to brain in STM-infected rats. World J Gastroenterol 2002; 8: 540–545
   PubMed Web of Science ®Google Scholar
• Kerschensteiner M., Meinl E., Hohlfeld R. Neuro-immune crosstalk in CNS diseases. Neuroscience 2008; 158: 1122–1132
   Google Scholar
• Barnard A., Layton D., Hince M., Sakkal S., Bernard C., Chidgey A., Boyd R. Impact of the neuroendocrine system on thymus and bone marrow function. Neuroimmunomodulation 2008; 15: 7–18
   PubMed Web of Science ®Google Scholar
• Aggarwal K., Silverman N. Positive and negative regulation of the Drosophila immune response. BMB Rep 2008; 41: 267–277
   PubMedGoogle Scholar
• Prigogine I., Wiame J. M. Biologie et thermodynamique des phénomènes irré versible [Biology and Thermodynamics of Irreversible Phenomena]. Experientia 1946; 2: 451–453
   PubMedGoogle Scholar
• Prigogine I. Introduction of Thermodynamics of Irreversible Processes. Interscience Publishers, New York 1967
   Google Scholar
• Schmidt A. Active patterns for self-optimization—Schemes for the design of intelligent mechatronic systems. IFIP International Federation for Information Processing, Biologically Inspired Cooperative Computing, Y. Pan, F. Rammig, H. Schmeck, M. Solar. Springer, Boston 2006; 147–156
   Google Scholar
• Young J. A., Dillin A. MAPping innate immunity. Proc Natl Acad Sci U S A 2004; 101: 12781–12782
   Google Scholar
• Boutros M., Agaisse H., Perrimon N. Sequential activation of signaling pathways during innate immune responses in Drosophila. Dev Cell 2002; 3: 711–722
   PubMed Web of Science ®Google Scholar
• Vély F., Vivier E. Natural killer cell receptor signaling pathway in mammals. Sci STKE 2005; 292: cm7
   Google Scholar
• Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004; 303: 1526–1529
   PubMed Web of Science ®Google Scholar